Frontiers in Clinical Drug Research - Hematology:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Singapore :
Bentham Science Publishers,
2020.
|
| Schriftenreihe: | Frontiers in Clinical Drug Research - Hematology Ser.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | Description based upon print version of record. CURRENT CHALLENGES AND FUTURE OUTLOOK. |
| Beschreibung: | 1 online resource (267 p.). |
| ISBN: | 9811469555 9789811469558 |
Internformat
MARC
| LEADER | 00000cam a2200000Mu 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-on1227390671 | ||
| 003 | OCoLC | ||
| 005 | 20240705115654.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 201219s2020 si o ||| 0 eng d | ||
| 040 | |a EBLCP |b eng |c EBLCP |d EBLCP |d N$T |d OCLCF |d OCLCO |d K6U |d OCLCQ |d OCLCO | ||
| 066 | |c (S | ||
| 020 | |a 9811469555 | ||
| 020 | |a 9789811469558 |q (electronic bk.) | ||
| 035 | |a (OCoLC)1227390671 | ||
| 050 | 4 | |a RB145 | |
| 082 | 7 | |a 616.15 |2 23 | |
| 049 | |a MAIN | ||
| 100 | 1 | |a Atta-ur-Rahman. | |
| 245 | 1 | 0 | |a Frontiers in Clinical Drug Research - Hematology |h [electronic resource]. |
| 260 | |a Singapore : |b Bentham Science Publishers, |c 2020. | ||
| 300 | |a 1 online resource (267 p.). | ||
| 490 | 1 | |a Frontiers in Clinical Drug Research - Hematology Ser. | |
| 500 | |a Description based upon print version of record. | ||
| 505 | 0 | |a Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- List of Contributors -- TRP Channels: Potential Therapeutic Targets in Blood Disorders -- Amritlal Mandal* -- INTRODUCTION -- TRP CHANNELS IN BLOOD DISORDERS -- TRP Channels and Abnormalities in RBCs -- Sickle Cell Disease (SCD) -- TRP Channels in Platelets Related Disorders -- TRPML and Iron-deficiency Anaemia -- TRPM6 in Dysregulated Blood and Serum Mg2+ Homeostasis -- TRP Channels and Hematological Malignancies -- TRPM Channels -- TRPM1 -- TRPM2 -- TRPM4 -- TRPM5 -- TRPM7 -- TRPM8 -- TRPV Channels -- TRPV1 | |
| 505 | 8 | |a Leukemia Cell Lines -- Adult T-Cell Leukemia (ATL) -- Multiple Myeloma (MM) -- TRPV2 -- TRPV5 and TRPV6 -- TRPC Channels -- TRPC1 -- TRPC2, TRPC3 and TRPC6 -- TRPC7 -- TRPP Channels -- CONCLUSIONS AND FUTURE DIRECTION -- ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Hypercoagulable States: Clinical Symptoms, Laboratory Markers and Management -- Pusparini Pusparini1 and Adi Hidayat2,* -- INTRODUCTION -- CLINICAL SYMPTOMS -- Venous Thromboembolism (VTE) -- Pathophysiology -- Clinical Presentation -- Evaluation -- Arterial Thromboembolism | |
| 505 | 8 | |a Protein S Deficiency -- Pathophysiology -- Epidemiology -- Laboratory Tests -- Management -- Antithrombin Deficiency -- Laboratory Tests -- Hyperhomocysteinemia -- Management -- Elevated Factor VIII -- Dysfibrinogenemia -- ALGORITHMIC APPROACH TO LABORATORY TESTING -- Patient Selection -- Reason to Test -- The "4P" Approach -- Whom to Test -- Whom Not to Test -- Points to Consider in Requests for Laboratory Examinations -- MANAGEMENT -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES | |
| 500 | |a CURRENT CHALLENGES AND FUTURE OUTLOOK. | ||
| 650 | 0 | |a Metabolism |x Disorders. |0 http://id.loc.gov/authorities/subjects/sh85084014 | |
| 650 | 2 | |a Metabolic Diseases |0 https://id.nlm.nih.gov/mesh/D008659 | |
| 650 | 6 | |a Troubles du métabolisme. | |
| 650 | 7 | |a Metabolism |x Disorders |2 fast | |
| 776 | 0 | 8 | |i Print version: |a Atta-ur-Rahman |t Frontiers in Clinical Drug Research - Hematology: Volume 4 |d Singapore : Bentham Science Publishers,c2020 |z 9789811469534 |
| 830 | 0 | |a Frontiers in Clinical Drug Research - Hematology Ser. | |
| 856 | 1 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2700845 |3 Volltext | |
| 856 | 1 | |l CBO01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2700845 |3 Volltext | |
| 880 | 8 | |6 505-00/(S |a Advanced Applications of Gene Therapy in the Treatment of Haematologic Disorders -- Mayasah Al-Nema and Anand Gaurav* -- INTRODUCTION -- GENE THERAPY TECHNIQUES USED IN THE TREATMENT OF BLOOD DISORDERS -- Gene Delivery Viral Vectors -- Haemophilia -- β-Haemoglobinopathies -- Genome Editing Technology (CRISPR-Cas9) -- How Does CRISPR Work in Bacteria-- Application of CRISPR-Cas9 in β-Haemoglobinopathies and Fanconi Anaemia -- Chimeric Antigen Receptor (CAR) T-Cell Therapy -- CAR T-Cell Therapy for Haematological Malignancies -- CAR Modified-Hematopoietic Stem Cells | |
| 880 | 8 | |6 505-00/(S |a Recurrent Venous Thromboembolism -- Risk Factors of Recurrent VTE -- RISK FACTORS/PREDISPOSING FACTORS -- Management -- HYPERCOAGULABLE DISORDERS -- Antiphospholipid Syndrome -- Lupus Anticoagulant Testing -- Anticardiolipin and β2GPI Antibody Testing -- Management -- Venous Thrombotic Events -- Direct Oral Anticoagulants (DOACs) -- Non-Anticoagulant Treatment of Thrombotic APS -- Factor V Leiden Mutation and Activated Protein C Resistance -- Factor V Leiden (FVL) -- Management -- Prothrombin Gene G20210A Mutations -- Management -- Protein C Deficiency -- Pathophysiology -- Management | |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL6424224 | ||
| 938 | |a EBSCOhost |b EBSC |n 2700845 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-on1227390671 |
|---|---|
| _version_ | 1813901694699831296 |
| adam_text | |
| any_adam_object | |
| author | Atta-ur-Rahman |
| author_facet | Atta-ur-Rahman |
| author_role | |
| author_sort | Atta-ur-Rahman |
| author_variant | a u au |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RB145 |
| callnumber-raw | RB145 |
| callnumber-search | RB145 |
| callnumber-sort | RB 3145 |
| callnumber-subject | RB - Pathology |
| collection | ZDB-4-EBA |
| contents | Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- List of Contributors -- TRP Channels: Potential Therapeutic Targets in Blood Disorders -- Amritlal Mandal* -- INTRODUCTION -- TRP CHANNELS IN BLOOD DISORDERS -- TRP Channels and Abnormalities in RBCs -- Sickle Cell Disease (SCD) -- TRP Channels in Platelets Related Disorders -- TRPML and Iron-deficiency Anaemia -- TRPM6 in Dysregulated Blood and Serum Mg2+ Homeostasis -- TRP Channels and Hematological Malignancies -- TRPM Channels -- TRPM1 -- TRPM2 -- TRPM4 -- TRPM5 -- TRPM7 -- TRPM8 -- TRPV Channels -- TRPV1 Leukemia Cell Lines -- Adult T-Cell Leukemia (ATL) -- Multiple Myeloma (MM) -- TRPV2 -- TRPV5 and TRPV6 -- TRPC Channels -- TRPC1 -- TRPC2, TRPC3 and TRPC6 -- TRPC7 -- TRPP Channels -- CONCLUSIONS AND FUTURE DIRECTION -- ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Hypercoagulable States: Clinical Symptoms, Laboratory Markers and Management -- Pusparini Pusparini1 and Adi Hidayat2,* -- INTRODUCTION -- CLINICAL SYMPTOMS -- Venous Thromboembolism (VTE) -- Pathophysiology -- Clinical Presentation -- Evaluation -- Arterial Thromboembolism Protein S Deficiency -- Pathophysiology -- Epidemiology -- Laboratory Tests -- Management -- Antithrombin Deficiency -- Laboratory Tests -- Hyperhomocysteinemia -- Management -- Elevated Factor VIII -- Dysfibrinogenemia -- ALGORITHMIC APPROACH TO LABORATORY TESTING -- Patient Selection -- Reason to Test -- The "4P" Approach -- Whom to Test -- Whom Not to Test -- Points to Consider in Requests for Laboratory Examinations -- MANAGEMENT -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES |
| ctrlnum | (OCoLC)1227390671 |
| dewey-full | 616.15 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.15 |
| dewey-search | 616.15 |
| dewey-sort | 3616.15 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04616cam a2200457Mu 4500</leader><controlfield tag="001">ZDB-4-EBA-on1227390671</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20240705115654.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">201219s2020 si o ||| 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">EBLCP</subfield><subfield code="b">eng</subfield><subfield code="c">EBLCP</subfield><subfield code="d">EBLCP</subfield><subfield code="d">N$T</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">K6U</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield></datafield><datafield tag="066" ind1=" " ind2=" "><subfield code="c">(S</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9811469555</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789811469558</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1227390671</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RB145</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616.15</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Atta-ur-Rahman.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Frontiers in Clinical Drug Research - Hematology</subfield><subfield code="h">[electronic resource].</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Singapore :</subfield><subfield code="b">Bentham Science Publishers,</subfield><subfield code="c">2020.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (267 p.).</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Frontiers in Clinical Drug Research - Hematology Ser.</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based upon print version of record.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- List of Contributors -- TRP Channels: Potential Therapeutic Targets in Blood Disorders -- Amritlal Mandal* -- INTRODUCTION -- TRP CHANNELS IN BLOOD DISORDERS -- TRP Channels and Abnormalities in RBCs -- Sickle Cell Disease (SCD) -- TRP Channels in Platelets Related Disorders -- TRPML and Iron-deficiency Anaemia -- TRPM6 in Dysregulated Blood and Serum Mg2+ Homeostasis -- TRP Channels and Hematological Malignancies -- TRPM Channels -- TRPM1 -- TRPM2 -- TRPM4 -- TRPM5 -- TRPM7 -- TRPM8 -- TRPV Channels -- TRPV1</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Leukemia Cell Lines -- Adult T-Cell Leukemia (ATL) -- Multiple Myeloma (MM) -- TRPV2 -- TRPV5 and TRPV6 -- TRPC Channels -- TRPC1 -- TRPC2, TRPC3 and TRPC6 -- TRPC7 -- TRPP Channels -- CONCLUSIONS AND FUTURE DIRECTION -- ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Hypercoagulable States: Clinical Symptoms, Laboratory Markers and Management -- Pusparini Pusparini1 and Adi Hidayat2,* -- INTRODUCTION -- CLINICAL SYMPTOMS -- Venous Thromboembolism (VTE) -- Pathophysiology -- Clinical Presentation -- Evaluation -- Arterial Thromboembolism</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Protein S Deficiency -- Pathophysiology -- Epidemiology -- Laboratory Tests -- Management -- Antithrombin Deficiency -- Laboratory Tests -- Hyperhomocysteinemia -- Management -- Elevated Factor VIII -- Dysfibrinogenemia -- ALGORITHMIC APPROACH TO LABORATORY TESTING -- Patient Selection -- Reason to Test -- The "4P" Approach -- Whom to Test -- Whom Not to Test -- Points to Consider in Requests for Laboratory Examinations -- MANAGEMENT -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">CURRENT CHALLENGES AND FUTURE OUTLOOK.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Metabolism</subfield><subfield code="x">Disorders.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85084014</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Metabolic Diseases</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D008659</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Troubles du métabolisme.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Metabolism</subfield><subfield code="x">Disorders</subfield><subfield code="2">fast</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Atta-ur-Rahman</subfield><subfield code="t">Frontiers in Clinical Drug Research - Hematology: Volume 4</subfield><subfield code="d">Singapore : Bentham Science Publishers,c2020</subfield><subfield code="z">9789811469534</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Frontiers in Clinical Drug Research - Hematology Ser.</subfield></datafield><datafield tag="856" ind1="1" ind2=" "><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2700845</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="1" ind2=" "><subfield code="l">CBO01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2700845</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="880" ind1="8" ind2=" "><subfield code="6">505-00/(S</subfield><subfield code="a">Advanced Applications of Gene Therapy in the Treatment of Haematologic Disorders -- Mayasah Al-Nema and Anand Gaurav* -- INTRODUCTION -- GENE THERAPY TECHNIQUES USED IN THE TREATMENT OF BLOOD DISORDERS -- Gene Delivery Viral Vectors -- Haemophilia -- β-Haemoglobinopathies -- Genome Editing Technology (CRISPR-Cas9) -- How Does CRISPR Work in Bacteria-- Application of CRISPR-Cas9 in β-Haemoglobinopathies and Fanconi Anaemia -- Chimeric Antigen Receptor (CAR) T-Cell Therapy -- CAR T-Cell Therapy for Haematological Malignancies -- CAR Modified-Hematopoietic Stem Cells</subfield></datafield><datafield tag="880" ind1="8" ind2=" "><subfield code="6">505-00/(S</subfield><subfield code="a">Recurrent Venous Thromboembolism -- Risk Factors of Recurrent VTE -- RISK FACTORS/PREDISPOSING FACTORS -- Management -- HYPERCOAGULABLE DISORDERS -- Antiphospholipid Syndrome -- Lupus Anticoagulant Testing -- Anticardiolipin and β2GPI Antibody Testing -- Management -- Venous Thrombotic Events -- Direct Oral Anticoagulants (DOACs) -- Non-Anticoagulant Treatment of Thrombotic APS -- Factor V Leiden Mutation and Activated Protein C Resistance -- Factor V Leiden (FVL) -- Management -- Prothrombin Gene G20210A Mutations -- Management -- Protein C Deficiency -- Pathophysiology -- Management</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL6424224</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">2700845</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-on1227390671 |
| illustrated | Not Illustrated |
| indexdate | 2024-10-25T15:50:58Z |
| institution | BVB |
| isbn | 9811469555 9789811469558 |
| language | English |
| oclc_num | 1227390671 |
| open_access_boolean | |
| owner | MAIN |
| owner_facet | MAIN |
| physical | 1 online resource (267 p.). |
| psigel | ZDB-4-EBA |
| publishDate | 2020 |
| publishDateSearch | 2020 |
| publishDateSort | 2020 |
| publisher | Bentham Science Publishers, |
| record_format | marc |
| series | Frontiers in Clinical Drug Research - Hematology Ser. |
| series2 | Frontiers in Clinical Drug Research - Hematology Ser. |
| spelling | Atta-ur-Rahman. Frontiers in Clinical Drug Research - Hematology [electronic resource]. Singapore : Bentham Science Publishers, 2020. 1 online resource (267 p.). Frontiers in Clinical Drug Research - Hematology Ser. Description based upon print version of record. Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- List of Contributors -- TRP Channels: Potential Therapeutic Targets in Blood Disorders -- Amritlal Mandal* -- INTRODUCTION -- TRP CHANNELS IN BLOOD DISORDERS -- TRP Channels and Abnormalities in RBCs -- Sickle Cell Disease (SCD) -- TRP Channels in Platelets Related Disorders -- TRPML and Iron-deficiency Anaemia -- TRPM6 in Dysregulated Blood and Serum Mg2+ Homeostasis -- TRP Channels and Hematological Malignancies -- TRPM Channels -- TRPM1 -- TRPM2 -- TRPM4 -- TRPM5 -- TRPM7 -- TRPM8 -- TRPV Channels -- TRPV1 Leukemia Cell Lines -- Adult T-Cell Leukemia (ATL) -- Multiple Myeloma (MM) -- TRPV2 -- TRPV5 and TRPV6 -- TRPC Channels -- TRPC1 -- TRPC2, TRPC3 and TRPC6 -- TRPC7 -- TRPP Channels -- CONCLUSIONS AND FUTURE DIRECTION -- ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Hypercoagulable States: Clinical Symptoms, Laboratory Markers and Management -- Pusparini Pusparini1 and Adi Hidayat2,* -- INTRODUCTION -- CLINICAL SYMPTOMS -- Venous Thromboembolism (VTE) -- Pathophysiology -- Clinical Presentation -- Evaluation -- Arterial Thromboembolism Protein S Deficiency -- Pathophysiology -- Epidemiology -- Laboratory Tests -- Management -- Antithrombin Deficiency -- Laboratory Tests -- Hyperhomocysteinemia -- Management -- Elevated Factor VIII -- Dysfibrinogenemia -- ALGORITHMIC APPROACH TO LABORATORY TESTING -- Patient Selection -- Reason to Test -- The "4P" Approach -- Whom to Test -- Whom Not to Test -- Points to Consider in Requests for Laboratory Examinations -- MANAGEMENT -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES CURRENT CHALLENGES AND FUTURE OUTLOOK. Metabolism Disorders. http://id.loc.gov/authorities/subjects/sh85084014 Metabolic Diseases https://id.nlm.nih.gov/mesh/D008659 Troubles du métabolisme. Metabolism Disorders fast Print version: Atta-ur-Rahman Frontiers in Clinical Drug Research - Hematology: Volume 4 Singapore : Bentham Science Publishers,c2020 9789811469534 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2700845 Volltext CBO01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2700845 Volltext 505-00/(S Advanced Applications of Gene Therapy in the Treatment of Haematologic Disorders -- Mayasah Al-Nema and Anand Gaurav* -- INTRODUCTION -- GENE THERAPY TECHNIQUES USED IN THE TREATMENT OF BLOOD DISORDERS -- Gene Delivery Viral Vectors -- Haemophilia -- β-Haemoglobinopathies -- Genome Editing Technology (CRISPR-Cas9) -- How Does CRISPR Work in Bacteria-- Application of CRISPR-Cas9 in β-Haemoglobinopathies and Fanconi Anaemia -- Chimeric Antigen Receptor (CAR) T-Cell Therapy -- CAR T-Cell Therapy for Haematological Malignancies -- CAR Modified-Hematopoietic Stem Cells 505-00/(S Recurrent Venous Thromboembolism -- Risk Factors of Recurrent VTE -- RISK FACTORS/PREDISPOSING FACTORS -- Management -- HYPERCOAGULABLE DISORDERS -- Antiphospholipid Syndrome -- Lupus Anticoagulant Testing -- Anticardiolipin and β2GPI Antibody Testing -- Management -- Venous Thrombotic Events -- Direct Oral Anticoagulants (DOACs) -- Non-Anticoagulant Treatment of Thrombotic APS -- Factor V Leiden Mutation and Activated Protein C Resistance -- Factor V Leiden (FVL) -- Management -- Prothrombin Gene G20210A Mutations -- Management -- Protein C Deficiency -- Pathophysiology -- Management |
| spellingShingle | Atta-ur-Rahman Frontiers in Clinical Drug Research - Hematology Frontiers in Clinical Drug Research - Hematology Ser. Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- List of Contributors -- TRP Channels: Potential Therapeutic Targets in Blood Disorders -- Amritlal Mandal* -- INTRODUCTION -- TRP CHANNELS IN BLOOD DISORDERS -- TRP Channels and Abnormalities in RBCs -- Sickle Cell Disease (SCD) -- TRP Channels in Platelets Related Disorders -- TRPML and Iron-deficiency Anaemia -- TRPM6 in Dysregulated Blood and Serum Mg2+ Homeostasis -- TRP Channels and Hematological Malignancies -- TRPM Channels -- TRPM1 -- TRPM2 -- TRPM4 -- TRPM5 -- TRPM7 -- TRPM8 -- TRPV Channels -- TRPV1 Leukemia Cell Lines -- Adult T-Cell Leukemia (ATL) -- Multiple Myeloma (MM) -- TRPV2 -- TRPV5 and TRPV6 -- TRPC Channels -- TRPC1 -- TRPC2, TRPC3 and TRPC6 -- TRPC7 -- TRPP Channels -- CONCLUSIONS AND FUTURE DIRECTION -- ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Hypercoagulable States: Clinical Symptoms, Laboratory Markers and Management -- Pusparini Pusparini1 and Adi Hidayat2,* -- INTRODUCTION -- CLINICAL SYMPTOMS -- Venous Thromboembolism (VTE) -- Pathophysiology -- Clinical Presentation -- Evaluation -- Arterial Thromboembolism Protein S Deficiency -- Pathophysiology -- Epidemiology -- Laboratory Tests -- Management -- Antithrombin Deficiency -- Laboratory Tests -- Hyperhomocysteinemia -- Management -- Elevated Factor VIII -- Dysfibrinogenemia -- ALGORITHMIC APPROACH TO LABORATORY TESTING -- Patient Selection -- Reason to Test -- The "4P" Approach -- Whom to Test -- Whom Not to Test -- Points to Consider in Requests for Laboratory Examinations -- MANAGEMENT -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES Metabolism Disorders. http://id.loc.gov/authorities/subjects/sh85084014 Metabolic Diseases https://id.nlm.nih.gov/mesh/D008659 Troubles du métabolisme. Metabolism Disorders fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85084014 https://id.nlm.nih.gov/mesh/D008659 |
| title | Frontiers in Clinical Drug Research - Hematology |
| title_auth | Frontiers in Clinical Drug Research - Hematology |
| title_exact_search | Frontiers in Clinical Drug Research - Hematology |
| title_full | Frontiers in Clinical Drug Research - Hematology [electronic resource]. |
| title_fullStr | Frontiers in Clinical Drug Research - Hematology [electronic resource]. |
| title_full_unstemmed | Frontiers in Clinical Drug Research - Hematology [electronic resource]. |
| title_short | Frontiers in Clinical Drug Research - Hematology |
| title_sort | frontiers in clinical drug research hematology |
| topic | Metabolism Disorders. http://id.loc.gov/authorities/subjects/sh85084014 Metabolic Diseases https://id.nlm.nih.gov/mesh/D008659 Troubles du métabolisme. Metabolism Disorders fast |
| topic_facet | Metabolism Disorders. Metabolic Diseases Troubles du métabolisme. Metabolism Disorders |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2700845 |
| work_keys_str_mv | AT attaurrahman frontiersinclinicaldrugresearchhematology |